InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,714.00
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.26
(
0.05%
)
Bitcoin
62,479.64
(
-0.67%
)
Post# of 62520
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Preciouslife1

Send PM Follow Ignore
Followers 89
Posts 19105
Boards Moderated 4
Alias Born 11/05/2005

Preciouslife1

Re: Preciouslife1 post# 62514

Wednesday, 10/15/2014 10:01:54 AM

Wednesday, October 15, 2014 10:01:54 AM

Post# of 62520
SUNSTAR Wednesday, 10/15/14 09:59:10 AM
Re: None
Post # of 193739
Bavituximab’s broad spectrum targets are cancers, enveloped viruses, like Ebola, and other diseases. It’s bavi’s universal target, PS, that is densely associated with these diseases, that will drive PPHM as the FDA approvals occur.

This broad spectrum universality of bavituximab will drive PPHM market cap growth exponentially from here going forward.

Bavi will be one the the first immunotherapy agents approved by FDA, IMO, allowing Peregrine to move from a small cap pharmaceutical, to directly competing with big pharmas for market share.

Broad spectrum means market leverage.

IMO

sunstar

Bull-markets are born on pessimism, grow on skepticism, mature on optimism and die on euphoria .. Sir John Templeton
Make your Life a Mission .... NOT an Intermission. † §|PL1|§

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up